Topical Tofacitinib for Patients with Lichen Planopilaris and/or Frontal Fibrosing Alopecia

    Li-Chi Chen, Chino Ogbutor, Kristen J. Kelley, Maryanne M. Senna
    Image of study
    TLDR Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.
    The document discusses the potential of topical tofacitinib, a JAK-1/3 inhibitor, as a treatment for lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA), which are forms of cicatricial alopecia. While oral JAK inhibitors have been used to treat these conditions, they carry risks of serious infections. Topical formulations, such as tofacitinib 2% cream, may offer a safer alternative. The document highlights two cases of women with FFA who showed improvement with this topical treatment, suggesting its potential efficacy with reduced systemic risks.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    2 / 2 results